I saw that as well, it is a form of cat scan (I am no sure if they use barium salts or not). I doubt it will impact GIVN sales, for two reasons, right now GIVN concentrates on the upper part of the gastrointestinal tract (and I am hoping they will go to the colon soon, but they do not have FDA approval for that yet). The second reason is that GIVN can give more than structural information, they yield actual images, thus even inflammations or discolorations should be visible. In edit, near the open sold SNDK at $79.39 for $.71. Bought CDWC near the open at $58.91.